GlassScriptPhysician profile
Donald T Kuhlman
NPI 1710902424
$6,087.54
in general payments reported to CMS, 2019-2025
41 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $438 · 2021: $555 · 2022: $429 · 2023: $1,206 · 2024: $1,291 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,859.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,202.04 | 2021-2025 | |
| Pfizer INC. | $891.13 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $521.98 | 2019-2025 | |
| Ucb, INC. | $454.51 | 2019-2024 | Briviact, Nayzilam, Rystiggo |
| Tg Therapeutics, INC. | $426.39 | 2023-2025 | |
| Genentech USA, INC. | $301.28 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Biogen, INC. | $269.22 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Lundbeck LLC | $197.87 | 2019-2025 | Vyepti |
| Inspire Medical Systems, INC. | $160.62 | 2024 | Inspire |
| Genzyme Corporation | $137.01 | 2019 | |
| Mdd US Operations, LLC | $123.41 | 2020-2025 | Gocovri |
| Acadia Pharmaceuticals INC | $103.13 | 2020 | |
| Sk Life Science, INC. | $88.44 | 2021-2024 | |
| Octapharma USA, INC. | $82.35 | 2023 | Panzyga |
| Eisai INC. | $80.83 | 2023-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Kuhlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.